Aleix Prat, Director of the Clínic Barcelona Comprehensive Cancer Center at Barcelona Clinical Hospital, shared a post on LinkedIn:
“Thrilled to celebrate the successful PhD defense of David Pesántez at the University of Barcelona!
His thesis, ‘Standardized Determination of ERBB2 mRNA and Immune Profiles in Advanced Gastric Cancer‘, represents years of rigorous work focused on improving molecular characterization and biomarker assessment in advanced HER2+ gastric cancer.
It has been a privilege to co-supervise this project together with Tamara Sauri.
Beyond the scientific achievements, I especially value David’s dedication, resilience, and commitment to translational research with real clinical impact.
Congratulations, Dr. Pesántez and the entire multidisciplinary team behind! Wishing you continued success in this exciting next stage.
I would also like to sincerely thank the members of the thesis committee (Olga Martínez Sáez, CINTA HIERRO CARBÓ Isidro Machado) for their time, insightful discussion, and valuable evaluation of the work.”
Other articles about Gastric Cancer on OncoDaily.